A panel at the Centers for Disease Control and Prevention (CDC) that advises the U.S. government on vaccine policy is expected to recommend lowering the age from 65 to 50 for getting a routine pneumococcal vaccination.
The decisions made by the Advisory Committee on Immunization Practices (ACIP) profoundly impact public health. ACIP’s recommendations dictate coverage requirements for Medicare, Medicaid, and private health plans, influencing access to life-saving vaccines for millions of Americans.